This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Merrell Pharmaceuticals, Inc., Merrell Dow Pharmaceuticals. Active years: 1995-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1996
Title: The Innovations of Axel Ganzhorn
Introduction
Axel Ganzhorn is a notable inventor based in Lingolsheim, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin inhibitors. With a total of 3 patents to his name, his work has implications for treating various medical conditions.
Latest Patents
Ganzhorn's latest patents focus on novel polyfluorinated alkyl derivatives of certain tripeptides. These inventions relate to methods for their preparation and their use in inhibiting thrombin and lung tryptase. The end-use applications of these inventions are particularly relevant as anti-coagulants, which can be useful in treating thrombophlebitis, coronary thrombosis, and asthma.
Career Highlights
Throughout his career, Axel Ganzhorn has worked with prominent companies in the pharmaceutical industry, including Merrell Pharmaceuticals, Inc. and Merrell Dow Pharmaceuticals. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Some of his notable coworkers include Bernhard Neises and Robert J Broersma. Their collaborations have likely played a role in advancing the research and development of thrombin inhibitors.
Conclusion
Axel Ganzhorn's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact the treatment of critical health conditions, showcasing the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile